BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34528556)

  • 1. Diagnostic potential of differentially regulated microRNAs among endometriosis, endometrioid ovarian cancer, and endometrial cancer.
    Kumari P; Sharma I; Saha SC; Srinivasan R; Minhas P
    J Cancer Res Ther; 2021; 17(4):1003-1011. PubMed ID: 34528556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of serum microRNAs as biomarkers for endometriosis, endometrioid carcinoma of ovary & endometrioid endometrial cancer.
    Kumari P; Sharma I; Saha SC; Srinivasan R; Bhardwaj P
    Indian J Med Res; 2022 Sep; 156(3):516-523. PubMed ID: 36751747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of microRNA detection in the diagnostics of endometrial cancer.
    Donkers H; Hirschfeld M; Weiß D; Erbes T; Jaeger M; Pijnenborg JMA; Bekkers R; Galaal K;
    Acta Obstet Gynecol Scand; 2021 Jun; 100(6):1148-1154. PubMed ID: 33705566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiRNAs in endometrioid endometrial cancer metastatic loci derived from positive lymph nodes.
    Wilczynski M; Senderowska D; Krawczyk T; Szymanska B; Malinowski A
    Acta Obstet Gynecol Scand; 2020 Aug; 99(8):1085-1091. PubMed ID: 32100871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-191 inhibits TNF-α induced apoptosis of ovarian endometriosis and endometrioid carcinoma cells by targeting DAPK1.
    Tian X; Xu L; Wang P
    Int J Clin Exp Pathol; 2015; 8(5):4933-42. PubMed ID: 26191186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
    Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
    Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of endometrioid endometrial carcinoma-associated microRNAs in tissue and plasma.
    Tsukamoto O; Miura K; Mishima H; Abe S; Kaneuchi M; Higashijima A; Miura S; Kinoshita A; Yoshiura K; Masuzaki H
    Gynecol Oncol; 2014 Mar; 132(3):715-21. PubMed ID: 24491411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profile of mammalian microRNAs in endometrioid adenocarcinoma.
    Wu W; Lin Z; Zhuang Z; Liang X
    Eur J Cancer Prev; 2009 Feb; 18(1):50-5. PubMed ID: 19077565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNAs related to angiogenesis are dysregulated in endometrioid endometrial cancer.
    Ramón LA; Braza-Boïls A; Gilabert J; Chirivella M; España F; Estellés A; Gilabert-Estellés J
    Hum Reprod; 2012 Oct; 27(10):3036-45. PubMed ID: 22904162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer.
    Suryawanshi S; Vlad AM; Lin HM; Mantia-Smaldone G; Laskey R; Lee M; Lin Y; Donnellan N; Klein-Patel M; Lee T; Mansuria S; Elishaev E; Budiu R; Edwards RP; Huang X
    Clin Cancer Res; 2013 Mar; 19(5):1213-24. PubMed ID: 23362326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of microRNA-200c expression levels with clinicopathological factors and prognosis in endometrioid endometrial cancer.
    Wilczynski M; Danielska J; Domanska-Senderowska D; Dzieniecka M; Szymanska B; Malinowski A
    Acta Obstet Gynecol Scand; 2018 May; 97(5):560-569. PubMed ID: 29355888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter methylation status of key genes and its implications in the pathogenesis of endometriosis, endometrioid carcinoma of ovary and endometrioid endometrial cancer.
    Kumari P; Sharma I; Saha SC; Srinivasan R; Sharma A
    J Cancer Res Ther; 2022 Dec; 18(Supplement):S328-S334. PubMed ID: 36510984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous ovarian endometrioid adenocarcinoma with a functioning stroma and endometrial endometrioid adenocarcinoma by different loss of heterozygosity findings.
    Takai N; Kai K; Tsuno A; Nasu K; Kashima K; Narahara H
    Arch Gynecol Obstet; 2011 Oct; 284(4):951-5. PubMed ID: 21046134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival.
    DeRycke MS; Andersen JD; Harrington KM; Pambuccian SE; Kalloger SE; Boylan KL; Argenta PA; Skubitz AP
    Am J Clin Pathol; 2009 Dec; 132(6):846-56. PubMed ID: 19926575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study.
    Záveský L; Jandáková E; Turyna R; Langmeierová L; Weinberger V; Záveská Drábková L; Hůlková M; Hořínek A; Dušková D; Feyereisl J; Minář L; Kohoutová M
    Pathol Oncol Res; 2015 Sep; 21(4):1027-35. PubMed ID: 25827090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA expression profiling of endometrial endometrioid adenocarcinomas and serous adenocarcinomas reveals profiles containing shared, unique and differentiating groups of microRNAs.
    Devor EJ; Hovey AM; Goodheart MJ; Ramachandran S; Leslie KK
    Oncol Rep; 2011 Oct; 26(4):995-1002. PubMed ID: 21725615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of MicroRNAs as Potential Biomarkers in Ovarian Endometriosis.
    Gu CL; Zhang Z; Fan WS; Li LA; Ye MX; Zhang Q; Zhang NN; Li Z; Meng YG
    Reprod Sci; 2020 Sep; 27(9):1715-1723. PubMed ID: 32651898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ascites-Derived Extracellular microRNAs as Potential Biomarkers for Ovarian Cancer.
    Záveský L; Jandáková E; Weinberger V; Minář L; Hanzíková V; Dušková D; Drábková LZ; Svobodová I; Hořínek A
    Reprod Sci; 2019 Apr; 26(4):510-522. PubMed ID: 29779470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of miR-145 and miR-143 might be associated with DNA methyltransferase 3B overexpression and worse prognosis in endometrioid carcinomas.
    Zhang X; Dong Y; Ti H; Zhao J; Wang Y; Li T; Zhang B
    Hum Pathol; 2013 Nov; 44(11):2571-80. PubMed ID: 24071015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
    Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
    Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.